Portfolio company
Neurophet
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software for brain image analysis and stimulation planning for clinicians, medical institutions and pharmaceutical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
BrainsightAl
This company develops artificial intelligence software for functional brain mapping to assist clinicians with neurological and psychiatric diagnosis and neurosurgical planning.
Neumarker
This company develops artificial intelligence software providing brain biomarkers to support clinical decisions and central nervous system drug development for hospitals and pharmaceutical firms.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
dEEGtal
This company develops artificial intelligence software to automate electroencephalogram analysis for neurologists diagnosing epilepsy.
Combinostics
This company develops AI software for quantifying brain images and patient data to support clinicians in diagnosing and managing neurological disorders.
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
